| BCBS Oklahoma Medical Policies | Extracranial Carotid Angioplasty or Stenting | 2025-12-15 |
| BCBS Oklahoma Medical Policies | Gene Therapies for Metachromatic Leukodystrophy | 2025-12-15 |
| BCBS Oklahoma Medical Policies | Gene Therapies for Sickle Cell Disease | 2025-12-15 |
| BCBS Oklahoma Medical Policies | Gene Therapies for Thalassemia | 2025-12-15 |
| BCBS Oklahoma Medical Policies | Hematopoietic Cell Transplantation for Acute Lymphoblastic | 2025-12-15 |
| BCBS Oklahoma Medical Policies | Hematopoietic Cell Transplantation for Breast Cancer | 2025-12-15 |
| BCBS Oklahoma Medical Policies | Hyperthermic Intraperitoneal Chemotherapy for Select Intra- | 2025-12-15 |
| BCBS Oklahoma Medical Policies | Implantable Cardioverter Defibrillators | 2025-12-15 |
| BCBS Oklahoma Medical Policies | Injectable Bulking Agents for the Treatment of Urinary and | 2025-12-15 |
| BCBS Oklahoma Medical Policies | Intravenous Antibiotic Therapy and Associated Diagnostic | 2025-12-15 |